Detalles de la búsqueda
1.
Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study.
Vaccines (Basel)
; 11(4)2023 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37112731
Resultados
1 -
1
de 1
1
Próxima >
>>